We are live on ! Find out more
VVA

Vida Ventures Advisors Portfolio holdings

AUM $29.4M
1-Year Est. Return 93.58%
This Fund
S&P 500
This Quarter Est. Return
+31.54%
1 Year Est. Return
+93.58%
3 Year Est. Return
+153.74%
5 Year Est. Return
+14.63%
10 Year Est. Return
–
AUM
$487M
AUM Growth
+$328M
Cap. Flow
+$311M
Cap. Flow %
63.91%
Top 10 Hldgs %
100%
Holding
8
New
3
Increased
–
Reduced
–
Closed
–

Top Buys

Rank Stock Value
1
PRAX icon
Praxis Precision Medicines
PRAX
+$114M
2
KNTE
Kinnate Biopharma Inc. Common Stock
KNTE
+$110M
3
KRON
Kronos Bio
KRON
+$86.8M

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
PRAX icon
1
Praxis Precision Medicines
PRAX
$8.8B
$162M 33.19%
+195,955
New +$114M
KNTE
2
DELISTED
Kinnate Biopharma Inc. Common Stock
KNTE
$109M 22.43%
+2,747,074
New +$110M
KRON
3
DELISTED
Kronos Bio
KRON
$82.6M 16.95%
+2,765,314
New +$86.8M
DYN icon
4
Dyne Therapeutics
DYN
$4.24B
$62.2M 12.76%
2,960,046
– –
ALLO icon
5
Allogene Therapeutics
ALLO
$604M
$45.4M 9.32%
1,798,163
– –
OYST
6
DELISTED
Oyster Point Pharma, Inc. Common Stock
OYST
$14.7M 3.01%
778,468
– –
QTTB icon
7
Q32 Bio
QTTB
$452M
$8.7M 1.79%
42,825
– –
ASMB icon
8
Assembly Biosciences
ASMB
$513M
$2.72M 0.56%
37,500
– –

Similar funds

NC
Nucleo Capital Sao Paulo, Sp, Brazil $29.1M AUM 59.16% 1-Year Est. Return
PIM
Pinnacle Investment Management Hong Kong $28.9M AUM 32% 1-Year Est. Return
NCPI
NewView Capital Partners I Burlingame, California $28M AUM 10.55% 1-Year Est. Return
TCM
Tybourne Capital Management Hong Kong $30.9M AUM 20.1% 1-Year Est. Return
RE
ROB Exploration New York $27.3M AUM 13.99% 1-Year Est. Return
VM
Valinor Management New York $32.2M AUM 44.16% 1-Year Est. Return
BCA
Burren Capital Advisors Gibraltar $33M AUM 47.67% 1-Year Est. Return
VCM
Vector Capital Management San Francisco, California $24.4M AUM 14.95% 1-Year Est. Return

Vida Ventures Advisors's Q4 2020 Portfolio in Review

As of Q4 2020, Vida Ventures Advisors held 8 positions worth $487M, up 205% from $160M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Vida Ventures Advisors deployed $311M of net new capital in Q4 2020, opening 3 new positions. Its largest new stake was Praxis Precision Medicines: 195,955 shares worth $162M.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

  • Vida Ventures Advisors's largest Q4 2020 buy was Praxis Precision Medicines: 195,955 shares worth $162M.
  • Vida Ventures Advisors's ten largest holdings make up 100% of its $487M portfolio in Q4 2020.
  • Vida Ventures Advisors opened 3 new positions and closed 0 in Q4 2020.
  • Vida Ventures Advisors's portfolio value rose 205% quarter-over-quarter to $487M.

Based on Vida Ventures Advisors's 13F filing for Q4 2020, filed 12 Feb 2021.